Consumer Goods M&A Stalls as Investors Trade Long-Term Bets for Quick Innovation

Fifteen percent. That's roughly how much deal volume evaporated from consumer products M&A in the first half of 2026, according to The Real Economy Blog at RSM US. The number isn't dramatic in isolation — markets exhale, markets inhale — but the reason behind it tells you everything about where capital allocators are stuck.

The dry powder is there. Sponsor balance sheets are flush. Strategics aren't suddenly stingy. What's missing is something far more stubborn: the ability to underwrite the future with any conviction. Call it regulatory fog, election-year theater, whatever helps you sleep — investors walked into 2026 expecting rate relief and clarity, got neither, and pulled the bid book shut.

The real story isn't the pause — it's the pivot

Here's what I'd watch. While headline volume craters, one buyer behavior is quietly accelerating. Corporate acquirers have stopped pretending organic R&D will save them. They're buying innovation instead — scooping up better-for-you and functional brands as plug-and-play extensions of their product pipeline.

The recent playbook reads like a who's-who of shortcut acquisitions: Unilever grabbing Grüns, Church & Dwight lining up Miss Mouth's, Farmer's Dog planning its Woofs deal. Translation? Big Food has concluded that building the next breakout brand in-house takes too long, costs too much, and probably won't work anyway. The M&A market isn't dead — it's become a research lab with a purchase order.

Where the friction still pays

Aged private equity vintages remain the most uncomfortable corner of this market. Several sponsors who planned exits in 2025 are now staring at recapitalizations, continuation funds, or just waiting — hoping an equity story materializes before their LPs lose patience.

What still trades? Add-ons, particularly in retail-adjacent consumer services: auto, quick service restaurants, fitness, veterinary. Multi-unit concepts with clean rollup math. Food and beverage, by contrast, is grinding through volume weakness, consumer trade-down, and input cost anxiety that won't quit. Pricing power is softening — promotional reload is back, which means margins are next.

The check-writers still active are chasing differentiated positioning, health-forward branding, and customer loyalty durable enough to survive a discounting war. Everyone else is sitting on the bench.

What I'd actually do with this

If you're a sponsor with a 2027 fundraise window, pressure-test your exit thesis now — not in Q4. If you're a strategic, recognize that your competitors are buying innovation because building it has become too expensive and too slow, and decide whether you're a buyer or a bystander before the auction calendar fills up again.

And if you're expecting a robust second-half recovery, lower the bar. RSM's read is that uncertainty persists through the midterms and into 2027. The mirage of a clean rebound keeps the calendar busy with false starts. Deal volume gets better, but it won't get easy.

McKinsey's been tracking how households are approaching holiday budgets. HBS Dealer flagged the latest consumer confidence print. Read both alongside this M&A picture, because the consumer trade-down story and the deal market story are the same story now. When shoppers get choosier, acquirers get pickier. The leverage just flows uphill.

The buyers with real conviction are already moving. The rest are waiting for someone else to call the bottom.

Spoiler: nobody's calling it.